An appeals court in Paris upended a €444.9 million ($474.3 million) fine against Novartis and Roche after rejecting allegations that they abused their dominance by protecting sales of a treatment for age-related macular degeneration. https://t.co/hQP1WQtSG3
— Law360 (@Law360) February 22, 2023
Source: Twitter
Discover more from Justice News247
Subscribe to get the latest posts sent to your email.